Morningstar
•
Oct 29, 2026
Baxter International Inc.: Baxter Earnings: New Management Team Continues to Make Progress and Boosts 2026 Guidance
Summary
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Colgate-Palmolive Company
Oct 30, 2026
•
CL
Daily – Vickers Top Buyers & Sellers for 10/30/2026
Oct 30, 2026
•
TFC, IBKR, ENVA, DINO, HBAN, TRV, XYL, PNFP, DHR
Technical Assessment: Bullish in the Intermediate-Term
Oct 30, 2026
•
TRGP, DGX
Analyst Report: Bristol-Myers Squibb Company
Oct 30, 2026
•
BMY
Analyst Report: Stryker Corporation
Oct 30, 2026
•
SYK
Analyst Profile
Julie Utterback
Senior Analyst
Julie Utterback is a senior equity analyst for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. She covers life sciences firms in the healthcare industry.Utterback initially joined Morningstar in 2005 as an equity analyst in the healthcare industry. At that time, she covered medical technology companies, including orthopedic device, medical equipment, and cardiac device firms. In 2010, she joined Morningstar's credit research team, initiating coverage on the entire healthcare industry and generally helping the organization expand and maintain its credit coverage across many industries. She held that senior credit analyst role until rejoining the equity team in April 2019.Prior to joining Morningstar, Utterback was an equity analyst at State Farm Insurance for several years. She holds a bachelor's degree in finance from the University of Illinois Urbana- Champaign. She also holds the Chartered Financial Analyst® designation.
